Fisher Wallace Labs
About this raise: Fisher Wallace Labs, with a valuation of $108.25 million, is raising funds on DealMaker Securities. The company is building and commercializing wearable brain stimulation technology for rapid treatment of anxiety, depression, insomnia, and other neuropsychiatric and cognitive disorders. Under temporary FDA clearance, Fisher Wallace commercialized its proof-of-concept Version 1.0 device and is on track to receive regulatory approval for the Version 2.0 technology. The business has sold over 100,000 units, has 14,000 prescribers, and has generated $40 million in revenue. Charles Fisher founded Fisher Wallace Labs in August 2019. The current crowdfunding campaign has a minimum target of $10,010.10 and a maximum target of $400,021.10. The campaign proceeds will be used for clinical research, regulatory consulting & legal fees, manufacturing, product development, and operations.
Investment Overview
Invested : $213,067
Deal Terms
Total Commitments ($USD)
- Platform
- DealMaker Securities
- Start Date
- 12/16/2024
- Close Date
- 01/02/2025
$10,010
$400,021
$98
Equity - Common
Seed
RegCF
$10.94
$108,250,000
Company & Team
Company
- Year Founded
- 2019
- Industry
- Fitness & Wellness
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- High
- Capital Intensity
- Low
Financials
- Revenue -57.4% YoY
- $2,019,527
- Monthly Burn
- $137,032
-
Runway
- 0.9 months
- Gross Margin
- 83%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $25,500,000
- VC Backed?
- Yes
| Offering Name | Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Fisher Wallace Labs | 01/02/2025 | DealMaker Securities | $108,250,000 | $213,067 | Equity - Common | Funded | RegCF |
| Fisher Wallace Labs | 10/17/2024 | DealMaker Securities | $106,700,000 | $276,274 | Equity - Common | Funded | RegCF |
| Fisher Wallace | 07/02/2024 | DealMaker Securities | $106,000,000 | $237,234 | Equity - Common | Funded | RegCF |
| Fisher Wallace | 04/18/2024 | DealMaker Securities | $104,100,000 | $413,448 | Equity - Common | Funded | RegCF |
| Fisher Wallace | 03/12/2024 | DealMaker Securities | $102,658,809 | $469,069 | Equity - Common | Funded | RegCF |
| Fisher Wallace | 01/24/2024 | DealMaker Securities | $102,170,000 | $532,202 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 10/04/2023 | StartEngine | $100,280,000 | $493,354 | Equity - Common | Funded | RegA+ |
| Fisher Wallace | 02/20/2023 | StartEngine | $81,567,588 | $1,281,201 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 09/01/2022 | StartEngine | $81,236,323 | $357,719 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 05/27/2022 | StartEngine | $80,048,889 | $1,279,724 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 10/26/2021 | StartEngine | $40,000,000 | $5,010,683 | Equity - Common | Funded | RegA+ |
| Fisher Wallace Laboratories | 03/09/2020 | StartEngine | $15,000,000 | $1,056,480 | Equity - Common | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.